#HVO hVIVO PLC – £3.2m hLAB project January 21, 2025 – Posted in: hVIVO (HVO)
hVIVO plc (AIM: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hLAB, the Group’s standalone virology and immunology laboratory service provider, has signed a new £2.7m contract with a US-based biotechnology client bringing the total value of this project to date to £3.2m. As part of this new contract, hLAB will act as the only contracted virology…
Continue reading